As one of the most common markers of CSCs, aldehyde dehydrogenase (ALDH) involves in the tumor development and progression processes of various carcinomas, including breast cancer, colorectal cancer, prostate cancer as well as bladder cancer [7–10]. This evidence concerns the gene LDHA and Familial prostate cancer.